Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST segment deviation is a term that describes displacement of the ST segment in an electrocardiogram (ECG) from its baseline (isoelectric line). The ST segment, normally flat and isoelectric, represents the period between the end of ventricular depolarization and the beginning of ventricular repolarization[1][2][3]. Changes in the height (elevation or depression) of the ST segment can indicate various cardiac pathologies. Most notably, **ST segment elevation** is a hallmark of acute transmural myocardial infarction and dictates urgent therapy. ST segment depression is associated with subendocardial ischemia or other nonischemic conditions. These findings are not molecular entities, but important clinical markers guiding diagnosis and treatment in cardiovascular medicine[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST segment deviation (ST deviation).